Can patients with hypothyroidism use Wegovy (semaglutide)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

People with hypothyroidism can generally take Wegovy (semaglutide) with appropriate medical supervision, as long as their hypothyroidism is well-controlled with medication like levothyroxine.

Important Considerations

  • It is essential to consult with a healthcare provider before starting Wegovy, as they need to evaluate the specific situation and monitor thyroid function during treatment 1.
  • Some patients may need adjustments to their thyroid medication dosage while on Wegovy, as weight loss can affect thyroid hormone requirements.
  • Additionally, be aware that some symptoms of hypothyroidism and Wegovy side effects can overlap, such as fatigue and constipation, so proper monitoring is important.

Mechanism of Action

  • Wegovy works by mimicking a hormone called GLP-1 to regulate appetite and food intake, which is a different mechanism than thyroid hormone replacement, making the two treatments generally compatible when properly managed 2.

Real-World Use

  • A recent study found that real-world semaglutide users generally resembled trial participants, but few follow the dose titration schemes tested in premarket clinical trials 1.

Thyroid Hormone Replacement

  • The American Thyroid Association task force on thyroid hormone replacement recommends that levothyroxine should remain the standard of care for treating hypothyroidism, and there is no consistently strong evidence for the superiority of alternative preparations over monotherapy with levothyroxine 3.

Metabolomics Profile

  • A study on the metabolomics profile in hypothyroid patients before and after thyroid hormone replacement found that some metabolic changes may persist after normalization of serum levels of FT3, FT4, and TSH 4.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.